Protocol for CHIEF (cochlear implants and inner ear inflammation) study; an observational, cross-sectional study of children and young people undergoing cochlear implantation.

<ns3:p>Introduction Cochlear implantation is a surgical intervention for people with severe-to-profound hearing loss. Electrodes in the cochlea generate electrical currents that stimulate the auditory nerve to elicit hearing. Despite the success of cochlear implants, some people do not receive the expected hearing benefits. One reason for this is that tissues in the cochlea vary in their response to implantation of the electrode array. Many people have a healthy wound-healing response that results in mature scar tissue (fibrosis). However, some individuals have a heightened inflammatory response associated with excessive fibrosis. This leads to greater electrical resistance to the current flow (impedance) and reduces the quality of electrical stimulation, both of which can lead to poorer hearing outcomes with the implant. Excessive inflammation can damage cochlear structures and result in loss of residual hearing. This study will increase our understanding of why some people have a heightened inflammatory response that leads to poorer hearing. We propose that there are detectable individual inflammatory differences between people when they are implanted, which may result in variable hearing outcomes following implantation. If we could understand and identify these differences, we could detect people who may be at risk of less favorable outcomes and use therapies to modulate inflammation and improve outcomes. Methods and analysis A cross-sectional study of children and young people undergoing cochlear implantation. On the day of surgery, a middle ear mucosa sample, swabs of the nasopharynx and middle ear, cochlear fluid, and blood samples will be collected. Samples will be analyzed using molecular techniques to determine the inflammatory status of the person at the time of implantation. Clinical hearing data will be collected for up to five years after implantation to explore the relationship between inflammation at the time of implantation and long-term hearing outcomes.</ns3:p>

Authors

Institutions

Publication Details

Journal
NIHR Open Research
Published
2025-03-04
DOI
https://doi.org/10.3310/nihropenres.13879.1
Citations
1
Primary Topic
Immune responses and vaccinations
Type
article
Field-Weighted Citation Impact
0.80

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protocol for CHIEF (cochlear implants and inner ear inflammation) study; an observational, cross-sectional study of children and young people undergoing cochlear implantation.

Jaya Nichani, Kate Hough, Iain Bruce, Tracey A. Newman et al.
1 citations
NIHR Open Research
Immune responses and vaccinations
0.80
article

Protocol for CHIEF (cochlear implants and inner ear inflammation) study; an observational, cross-sectional study of children and young people undergoing cochlear implantation.

Jaya Nichani, Kate Hough, Iain Bruce, Tracey A. Newman, C. Findlay
article en
1 citations

Abstract

<ns3:p>Introduction Cochlear implantation is a surgical intervention for people with severe-to-profound hearing loss. Electrodes in the cochlea generate electrical currents that stimulate the auditory nerve to elicit hearing. Despite the success of cochlear implants, some people do not receive the expected hearing benefits. One reason for this is that tissues in the cochlea vary in their response to implantation of the electrode array. Many people have a healthy wound-healing response that results in mature scar tissue (fibrosis). However, some individuals have a heightened inflammatory response associated with excessive fibrosis. This leads to greater electrical resistance to the current flow (impedance) and reduces the quality of electrical stimulation, both of which can lead to poorer hearing outcomes with the implant. Excessive inflammation can damage cochlear structures and result in loss of residual hearing. This study will increase our understanding of why some people have a heightened inflammatory response that leads to poorer hearing. We propose that there are detectable individual inflammatory differences between people when they are implanted, which may result in variable hearing outcomes following implantation. If we could understand and identify these differences, we could detect people who may be at risk of less favorable outcomes and use therapies to modulate inflammation and improve outcomes. Methods and analysis A cross-sectional study of children and young people undergoing cochlear implantation. On the day of surgery, a middle ear mucosa sample, swabs of the nasopharynx and middle ear, cochlear fluid, and blood samples will be collected. Samples will be analyzed using molecular techniques to determine the inflammatory status of the person at the time of implantation. Clinical hearing data will be collected for up to five years after implantation to explore the relationship between inflammation at the time of implantation and long-term hearing outcomes.</ns3:p>

NIHR Open ResearchVol. 5
University Hospital Southampton NHS Foundation Trust (GB), University of Manchester (GB), Royal Manchester Children's Hospital (GB), University of Southampton (GB)
National Institute for Health and Care Research, Department of Health and Social Care, Manchester Biomedical Research Centre, Research for Patient Benefit Programme
Openalex Percentile: Top 31%
Immune responses and vaccinations
0.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.